Advent France Biotechnology

General contacts
Investor type

VC

Founded

2015

AUM

$65 M

Location

Paris, Île-de-France, France

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

Europe
Investor profile last updated: 21 August, 2026

Profile

Advent France Biotechnology (AdBio partners) is a venture capital firm based in Paris, France and Barcelona, Spain. Specializing in early-stage investments, the firm was established to support life sciences startups across Europe. AdBio partners emphasizes a strong entrepreneurial spirit in their investments. Their team is composed of industry experts with extensive backgrounds in biotechnology and healthcare, which differentiates them by providing valuable insights and support for their portfolio companies.

AdBio partners focuses exclusively on the life sciences sector, with a particular interest in biotechnology and healthtech startups. They invest at the early stages, predominantly in Europe, aiding startups to develop their cutting-edge technologies quickly. Their notable fund, AFB Seed-Fund I, is backed by InnovFin Equity and the European Union under the Horizon 2020 Financial Instruments, aiming to enhance investment in productive sectors across Europe.

Notable investments in AdBio partners' portfolio include companies like SparingVision, Tenpoint Therapeutics, and Agomab, which are advancing in areas such as gene therapy, regenerative medicine, and novel therapeutics. They partner with companies spearheading new discoveries in healthcare and support their growth with both strategic insight and capital.

Industry

AgriTech Biotechnology Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech

Contacts

Name
Title
Email
Social Networks
avatar
Clément BERTHOLET Managing Partner
Managing Partner
c•••@•••
avatar
Mounia AZZI Partner
Partner
m•••@•••
LinkedIn
Upgrade to see contacts
avatar
ShQInBPiLOFgN6z2 ShQInBPiLOFgN6z2
ShQInBPiLOFgN6z2
[email protected]
linkedin twitter
avatar
ShQInBPiLOFgN6z2 ShQInBPiLOFgN6z2
ShQInBPiLOFgN6z2
[email protected]
linkedin twitter
avatar
ShQInBPiLOFgN6z2 ShQInBPiLOFgN6z2
ShQInBPiLOFgN6z2
[email protected]
linkedin twitter
Investment-team contacts for Advent France Biotechnology — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Advent France Biotechnology

Advent France Biotechnology is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $0-1 m.
Advent France Biotechnology is located in Paris, Île-de-France, France.
Advent France Biotechnology was founded in 2015.
Advent France Biotechnology invests in companies and startups in AgriTech, Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
Advent France Biotechnology invests in companies and startups in Europe.
Advent France Biotechnology invests in companies and startups at Seed, Series A.
Advent France Biotechnology usually invests $0-1 m on average.
Advent France Biotechnology has around $65m assets under management.
Advent France Biotechnology can be reached through its website adventfb.com/en, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Advent France Biotechnology — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Advent France Biotechnology directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.